Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Stephanie Anderson

Novo Nordisk Postdoctoral Research Fellow

I received my undergraduate BSc. (Hons.) degree in Genetics and an MRes. in Translational Medicine with distinction from the University of Glasgow. I completed my DPhil in Physiology, Anatomy and Genetics at the University of Oxford in Prof. Damian Tyler’s group where my research focused on the application of magnetic resonance imaging and spectroscopy techniques to the study of cardiac structure, function, metabolism and energetics in cardiovascular disease and diabetes. During my DPhil I worked on collaborative projects with GSK, Astra Zeneca and Queen Mary University London to assess pharmacological modulation of cardiac metabolism and energetics in diabetes and heart failure. I have a particular interest in how inflammation in diabetes affects cardiac function and the immunophenotype of the diabetic heart.

I began my Novo Nordisk Postdoctoral Research Fellowship, in March 2024 to work within the Akbar and Choudhury groups in Cardiovascular Medicine. My fellowship project aims to use an integrated multi-omics analysis approach to characterise early detection of VCAM-1 positive plasma extracellular vesicles as a prognostic tool in the diagnosis of acute myocardial infarction in patients with diabetes, with a focus on the role VCAM-1+ extracellular vesicles have in immunomodulation and any potential novel therapeutic avenues this may lead to.